The majority of country information documents presented is based on templates developed by the Department’s experts and its collaborators. The country documents were predominantly written by country experts (usually policy-makers and technical staff working in competent authorities for pharmaceutical pricing and reimbursement) as part of their contributions to the PPRI project. Staff of the administrations prepared these reports on top of their daily tasks. Thus some of country information might be out-dated since there are limited resources for updating. Please check the dates of the country reports before use.